Telomir Pharmaceuticals (NASDAQ:TELO) on Tuesday announced results from recent preclinical studies demonstrating the ability of Telomir-1 to fully reverse oxidative stress in human cell lines. Telomir ...

A novel mechanism that enables cells to maintain energy production even when their main power supply drops/fails has been ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...